Efficacy of afatinib or osimertinib plus cetuximab combination therapy for non-small-cell lung cancer with EGFR exon 20 insertion mutations

出版年份 2018 全文链接

标题

作者

关键词

EGFR tyrosine kinase inhibitor, EGFR, exon 20 insertion mutations, Lung cancer, Afatinib, Cetuximab

出版物

Volume 127, Issue -, Pages 146-152

出版商

Elsevier BV

发表日期

2018-11-29

DOI

10.1016/j.lungcan.2018.11.039

联系作者

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started